D. Martin Gershon

Dr. D. Martin Gershon is a leading healthcare and life sciences innovation strategist and advisor for Fortune 500 companies, venture capital investor, designated Standard & Poor’s healthcare industry leader, former Pictet Asset Management advisory board Mmmber, chairman of the Aspen Institute Business of Health Program, Memorial Sloan-Kettering Cancer Center Mayday Fellow, advisor to the Harvard Innovation Labs and has 20 years of experience as a neuroscientist, oncologist/immunologist, healthcare economist and FDA healthcare regulatory attorney.

Dr. Gershon has served as a senior advisor in strategic partnerships and commercialization including go-to-market strategies to McKinsey, Goldman Sachs, Bain Capital, TPG, BlackRock, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer and Novartis.

Dr. Gershon founded the Endeavor Life Science Fund investing in groundbreaking companies like Moderna and 69 life sciences companies that are reshaping healthcare, possessing disruptive technologies with strong, scalable commercial potential and social impact, driven by great entrepreneurs/founders with cutting-edge innovations that look for coaching and strategic partnerships to build their early stage companies into the next unicorns.